Activity of high-dose epirubicin in advanced non-small cell lung cancer
- 31 October 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (10) , 1231-1234
- https://doi.org/10.1016/0277-5379(91)90087-t
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phase II study of high-dose epirubicin in non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- High-dose epiribicin for untreated patients with advanced tumours: a phase I studyEuropean Journal of Cancer and Clinical Oncology, 1990
- Phase II Study of High-Dose Epirubicin in Non-Small Cell Lung CancerPublished by S. Karger AG ,1989
- Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lungEuropean Journal of Cancer and Clinical Oncology, 1984
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Reporting results of cancer treatmentCancer, 1981
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979